Literature DB >> 22486245

Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.

Paola Maccioni1, Alessandro Zaru, Barbara Loi, Carla Lobina, Mauro A M Carai, Gian Luigi Gessa, Alessandro Capra, Claudia Mugnaini, Serena Pasquini, Federico Corelli, Petri Hyytiä, Lawrence Lumeng, Giancarlo Colombo.   

Abstract

BACKGROUND: Administration of the GABA(B) receptor agonist, baclofen, and positive allosteric modulator, GS39783, has been repeatedly reported to suppress multiple alcohol-related behaviors, including operant oral alcohol self-administration, in rats. This study was designed to compare the effect of baclofen and GS39783 on alcohol self-administration in 3 lines of selectively bred, alcohol-preferring rats: Indiana alcohol-preferring (P), Sardinian alcohol-preferring (sP), and Alko Alcohol (AA).
METHODS: Rats of each line were initially trained to respond on a lever, on a fixed ratio (FR) 4 (FR4) schedule of reinforcement, to orally self-administer alcohol (15%, v/v) in daily 30-minute sessions. Once responding reached stable levels, rats were exposed to a sequence of experiments testing baclofen (0, 1, 1.7, and 3 mg/kg; i.p.) and GS39783 (0, 25, 50, and 100 mg/kg; i.g.) on FR4 and progressive ratio (PR) schedules of reinforcement. Finally, to assess the specificity of baclofen and GS39783 action, rats were slightly food-deprived and trained to lever-respond for food pellets.
RESULTS: The rank of order of the reinforcing and motivational properties of alcohol was P>sP>AA rats. Under both FR and PR schedules of reinforcement, the rank of order of potency and efficacy of baclofen and GS39783 in suppressing alcohol self-administration was P>sP>AA rats. Only the highest dose of baclofen reduced lever-responding for food pellets; this effect was common to all 3 rat lines. Conversely, no dose of GS39783 altered lever-responding for food in any rat line.
CONCLUSIONS: These results suggest that: (i) the strength of the reinforcing and motivational properties of alcohol differ among P, sP, and AA rats; (ii) the reinforcing and motivational properties of alcohol in P, sP, and AA rats are differentially sensitive to treatment with baclofen and GS39783; (iii) the heterogeneity in sensitivity to baclofen and GS39783 of alcohol self-administration in P, sP, and AA rats may resemble the differential effectiveness of pharmacotherapies among the different typologies of human alcoholics; and (iv) the GABA(B) receptor is part of the neural substrate mediating the reinforcing and motivational properties of alcohol.
Copyright © 2012 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486245      PMCID: PMC3396797          DOI: 10.1111/j.1530-0277.2012.01782.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  93 in total

1.  Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement.

Authors:  K Brebner; R Phelan; D C Roberts
Journal:  Pharmacol Biochem Behav       Date:  2000-08       Impact factor: 3.533

2.  Suppression of symptoms of alcohol dependence and craving using high-dose baclofen.

Authors:  William Bucknam
Journal:  Alcohol Alcohol       Date:  2006-12-15       Impact factor: 2.826

Review 3.  Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence.

Authors:  H M Pettinati
Journal:  Alcohol Clin Exp Res       Date:  1996-10       Impact factor: 3.455

4.  Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations.

Authors:  Giancarlo Colombo; Salvatore Serra; Giovanni Vacca; Mauro A M Carai; Gian Luigi Gessa
Journal:  Eur J Pharmacol       Date:  2006-09-08       Impact factor: 4.432

5.  The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.

Authors:  J M Wierońska; M Kusek; K Tokarski; J Wabno; W Froestl; A Pilc
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.

Authors:  James C Garbutt; Alexei B Kampov-Polevoy; Robert Gallop; Linda Kalka-Juhl; Barbara A Flannery
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

7.  The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration.

Authors:  Paola Maccioni; Andrew W Thomas; Mauro A M Carai; Gian Luigi Gessa; Pari Malherbe; Giancarlo Colombo
Journal:  Drug Alcohol Depend       Date:  2010-01-20       Impact factor: 4.492

8.  Effect of baclofen on alcohol and sucrose self-administration in rats.

Authors:  Kristin K Anstrom; Howard C Cromwell; Tania Markowski; Donald J Woodward
Journal:  Alcohol Clin Exp Res       Date:  2003-06       Impact factor: 3.455

9.  The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats.

Authors:  Giancarlo Colombo; Salvatore Serra; Giuliana Brunetti; Giuliana Atzori; Marialaura Pani; Giovanni Vacca; Giovanni Addolorato; Wolfgang Froestl; Mauro A M Carai; Gian Luigi Gessa
Journal:  Alcohol Alcohol       Date:  2002 Sep-Oct       Impact factor: 2.826

Review 10.  Subtypes of alcoholism and their role in therapy.

Authors:  O M Lesch; H Walter
Journal:  Alcohol Alcohol       Date:  1996-03       Impact factor: 2.826

View more
  32 in total

1.  Anxiety-like behaviors at the end of the nocturnal period in sP rats with a "history" of unpredictable, limited access to alcohol.

Authors:  Giancarlo Colombo; Carla Lobina; Paola Maccioni; Mauro A M Carai; Irene Lorrai; Alessandro Zaru; Andrea Contini; Claudia Mugnaini; Federico Corelli; Gian Luigi Gessa
Journal:  Alcohol       Date:  2015-07-21       Impact factor: 2.405

2.  Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction.

Authors:  Valentina Vengeliene; Tatiane T Takahashi; Olga A Dravolina; Irina Belozertseva; Edwin Zvartau; Anton Y Bespalov; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2018-04-12       Impact factor: 4.530

Review 3.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

4.  Baclofen and naltrexone effects on alcohol self-administration: Comparison of treatment initiated during abstinence or ongoing alcohol access in baboons.

Authors:  August F Holtyn; Barbara J Kaminski; Elise M Weerts
Journal:  Drug Alcohol Depend       Date:  2017-07-18       Impact factor: 4.492

Review 5.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 6.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

7.  Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors.

Authors:  Paola Maccioni; Giancarlo Colombo; Irene Lorrai; Alessandro Zaru; Mauro A M Carai; Gian Luigi Gessa; Antonella Brizzi; Claudia Mugnaini; Federico Corelli
Journal:  Psychopharmacology (Berl)       Date:  2017-05-24       Impact factor: 4.530

Review 8.  Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.

Authors:  Paola Maccioni; Giancarlo Colombo
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 9.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 10.  Scheduled access alcohol drinking by alcohol-preferring (P) and high-alcohol-drinking (HAD) rats: modeling adolescent and adult binge-like drinking.

Authors:  Richard L Bell; Zachary A Rodd; Eric A Engleman; Jamie E Toalston; William J McBride
Journal:  Alcohol       Date:  2013-10-31       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.